{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T16:50:42Z","timestamp":1790268642137,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/j.ejphar.2022.175028","type":"journal-article","created":{"date-parts":[[2022,5,13]],"date-time":"2022-05-13T04:16:20Z","timestamp":1652415380000},"page":"175028","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Dihydroartemisinin inhibits the growth of pancreatic cells by inducing ferroptosis and activating antitumor immunity"],"prefix":"10.1016","volume":"926","author":[{"given":"Hongbo","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuzhen","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lanqiu","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaoying","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangfei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2022.175028_bib1","article-title":"Iron metabolism in the tumor microenvironment-implications for anti-cancer immune response","volume":"10","author":"Alessandro","year":"2021","journal-title":"J. Cell."},{"key":"10.1016\/j.ejphar.2022.175028_bib2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.semcancer.2018.08.001","article-title":"NK cells shape pancreatic and oral tumor microenvironments; role in inhibition of tumor growth and metastasis","volume":"53","author":"Anahid","year":"2018","journal-title":"[J] .Semin Cancer Biol"},{"key":"10.1016\/j.ejphar.2022.175028_bib3","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1186\/s13046-019-1413-7","article-title":"Dihydroartemisinin-induced unfolded protein response feedback attenuates ferroptosis via PERK\/ATF4\/HSPA5 pathway in glioma cells.[J]","volume":"38","author":"Chen","year":"2019","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.ejphar.2022.175028_bib4","doi-asserted-by":"crossref","first-page":"3375","DOI":"10.2147\/OTT.S249046","article-title":"Dihydroartemisinin prevents progression and metastasis of head and neck squamous cell carcinoma by inhibiting polarization of macrophages in tumor microenvironment","volume":"13","author":"Chen","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2022.175028_bib5","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1038\/s41556-019-0305-6","article-title":"ALOX12 is required for p53-mediated tumour suppression through a distinct ferroptosis pathway","volume":"21","author":"Chu","year":"2019","journal-title":"[J]. Nat Cell Biol"},{"issue":"2","key":"10.1016\/j.ejphar.2022.175028_bib6","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/ijbs.50364","article-title":"Dihydroartemisinin: a potential natural anticancer drug","volume":"17","author":"Dai","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175028_bib7","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/ijbs.50364","article-title":"Dihydroartemisinin: a potential natural anticancer drug. [J]","volume":"17","author":"Dai","year":"2021","journal-title":"Int. J. Biol. Sci."},{"issue":"2","key":"10.1016\/j.ejphar.2022.175028_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.7150\/ijbs.50364","article-title":"Dihydroartemisinin: a potential natural anticancer drug. [J]","volume":"17","author":"Dai","year":"2021","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.ejphar.2022.175028_bib9","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1200\/EDBK_237987","article-title":"Reprogramming the tumor microenvironment to improve immunotherapy: emerging strategies and combination therapies","volume":"39","author":"Datta","year":"2019","journal-title":"[J]. Am Soc Clin Oncol Educ Book."},{"issue":"5","key":"10.1016\/j.ejphar.2022.175028_bib10","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.ccell.2019.09.006","article-title":"Combination immunotherapy with CAR T cells and checkpoint blockade for the treatment of solid tumors. [J]","volume":"36","author":"Grosser","year":"2019","journal-title":"Cancer Cell"},{"key":"10.1016\/j.ejphar.2022.175028_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nature14344","article-title":"Ferroptosis as a p53-mediated activity during tumour suppression","volume":"520","author":"Jiang","year":"2015","journal-title":"[J]. Nature"},{"key":"10.1016\/j.ejphar.2022.175028_bib12","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1038\/s41590-020-0761-y","article-title":"Regulation and modulation of antitumor immunity in pancreatic cancer.[J]","volume":"21","author":"Joshua","year":"2020","journal-title":"Nat. Immunol."},{"issue":"4703","key":"10.1016\/j.ejphar.2022.175028_bib13","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.3887571","article-title":"Qinghaosu (artemisinin): an antimalarial drug from China. [J]","volume":"228","author":"Klayman","year":"1985","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2022.175028_bib14","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1158\/2159-8290.CD-19-0338","article-title":"Radiotherapy and immunotherapy promote tumoral lipid oxidation and ferroptosis via synergistic repression of SLC7A11","volume":"9","author":"Lang","year":"2019","journal-title":"[J]. Cancer Discov"},{"issue":"8","key":"10.1016\/j.ejphar.2022.175028_bib15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.intimp.2006.03.004","article-title":"Dihydroarteannuin ameliorates lupus symptom of BXSB mice by inhibiting production of TNF-alpha and blocking the signaling pathway NF-kappa B translocation. [J]","volume":"6","author":"Li","year":"2006","journal-title":"Int. Immunopharm."},{"key":"10.1016\/j.ejphar.2022.175028_bib16","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.freeradbiomed.2019.08.013","article-title":"Protective effect of dihydroartemisinin in inhibiting senescence of myeloid-derived suppressor cells from lupus mice via Nrf2\/HO-1 pathway","volume":"143","author":"Li","year":"2019","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejphar.2022.175028_bib17","doi-asserted-by":"crossref","first-page":"2563","DOI":"10.2147\/OTT.S297785","article-title":"Dihydroartemisinin as a sensitizing agent in cancer therapies","volume":"14","author":"Li","year":"2021","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2022.175028_bib18","article-title":"Impact of TCM on tumor-infiltrating myeloid precursors in the tumor microenvironment. [J]","volume":"9","author":"Liu","year":"2021","journal-title":"Front. Cell Dev. Biol."},{"key":"10.1016\/j.ejphar.2022.175028_bib19","article-title":"A novel ferroptosis-associated gene signature to predict prognosis in patients with uveal melanoma","volume":"11","author":"Luo","year":"2021","journal-title":"J. Diagn."},{"key":"10.1016\/j.ejphar.2022.175028_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1186\/s13020-019-0270-9","article-title":"Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine","volume":"14","author":"Luo","year":"2019","journal-title":"J. Chin. Med."},{"key":"10.1016\/j.ejphar.2022.175028_bib21","doi-asserted-by":"crossref","first-page":"128","DOI":"10.3389\/fimmu.2019.00128","article-title":"CAR T cells for solid tumors: new strategies for finding, infiltrating, and surviving in the tumor microenvironment. [J]","volume":"10","author":"Martinez","year":"2019","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.ejphar.2022.175028_bib22","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1038\/nm.3394","article-title":"Microenvironmental regulation of tumor progression and metastasis","volume":"19","author":"Quail","year":"2013","journal-title":"J. Nat. Med."},{"key":"10.1016\/j.ejphar.2022.175028_bib23","doi-asserted-by":"crossref","first-page":"11291","DOI":"10.2147\/OTT.S232852","article-title":"Ferroptosis in carcinoma: regulatory mechanisms and new method for cancer therapy. [J]","volume":"12","author":"Shi","year":"2019","journal-title":"OncoTargets Ther."},{"issue":"6","key":"10.1016\/j.ejphar.2022.175028_bib24","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s11912-021-01057-3","article-title":"Locally advanced pancreatic cancer: percutaneous management using ablation, brachytherapy, intra-arterial chemotherapy, and intra-tumoral immunotherapy. [J]","volume":"23","author":"Timmer","year":"2021","journal-title":"Curr. Oncol. Rep."},{"key":"10.1016\/j.ejphar.2022.175028_bib25","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41586-019-1170-y","article-title":"CD8 T cells regulate tumour ferroptosis during cancer immunotherapy. [J]","volume":"569","author":"Wang","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.ejphar.2022.175028_bib26","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1002\/2211-5463.12823","article-title":"Histone demethylase KDM3B protects against ferroptosis by upregulating SLC7A11. [J]","volume":"10","author":"Wang","year":"2020","journal-title":"FEBS Open Bio"},{"issue":"8","key":"10.1016\/j.ejphar.2022.175028_bib28","doi-asserted-by":"crossref","first-page":"4900","DOI":"10.1111\/jcmm.14511","article-title":"Molecular mechanisms of ferroptosis and its role in cancer therapy. [J]","volume":"23","author":"Xu","year":"2019","journal-title":"J. Cell Mol. Med."},{"key":"10.1016\/j.ejphar.2022.175028_bib29","doi-asserted-by":"crossref","first-page":"10829","DOI":"10.2147\/OTT.S248492","article-title":"Dihydroartemisinin inhibits the proliferation, colony formation and induces ferroptosis of lung cancer cells by inhibiting PRIM2\/SLC7A11 Axis","volume":"13","author":"Yuan","year":"2020","journal-title":"OncoTargets Ther."},{"key":"10.1016\/j.ejphar.2022.175028_bib30","article-title":"Optimization of the process for purifying icariin from Herba Epimedii by macroporous resin and the regulatory role of icariin in the tumor immune microenvironment","volume":"118","author":"Zheng","year":"2019","journal-title":"[J]. Biomed Pharmacother"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922002898?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299922002898?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T23:03:58Z","timestamp":1757977438000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299922002898"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7]]},"references-count":29,"alternative-id":["S0014299922002898"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175028","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dihydroartemisinin inhibits the growth of pancreatic cells by inducing ferroptosis and activating antitumor immunity","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2022.175028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"175028"}}